Shopping Cart 0
Cart Subtotal
USD 0

Pharmaceuticals in Spain

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 350

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 700

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 1050
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Pharmaceuticals in Spain

Summary

Pharmaceuticals in Spain industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Spain pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The Spanish pharmaceuticals market had total revenues of USD 24.1bn in 2017, representing a compound annual growth rate (CAGR) of 1.2% between 2013 and 2017.

- Like many other European countries, an aging population and the diseases associated with this have driven growth in the pharmaceutical market.

- The primary factor disrupting pharma growth in the Spanish market is the continued economic uncertainty. This has reduced public healthcare budgets and simultaneously restricted the spending power of consumers in the private sector as well.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Spain

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Spain

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Spain pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the Spain pharmaceuticals market by value in 2017?

- What will be the size of the Spain pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the Spain pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in Spain's pharmaceuticals market?

READ MORE

Table Of Content

Scope

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Geography segmentation 10

Market share 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 16

New entrants 17

Threat of substitutes 19

Degree of rivalry 20

Leading Companies 22

Almirall S.A. 22

AstraZeneca PLC 25

GlaxoSmithKline Plc 28

Macroeconomic Indicators 32

Country data 32

Methodology 34

Industry associations 35

Related MarketLine research 35

Appendix 36

About MarketLine 36


List Of Figure

List of Figures

Figure 1: Spain pharmaceuticals market value: USD billion, 2013-17

Figure 2: Spain pharmaceuticals market geography segmentation: % share, by value, 2017

Figure 3: Spain pharmaceuticals market share: % share, by value, 2017

Figure 4: Spain pharmaceuticals market value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the pharmaceuticals market in Spain, 2017

Figure 6: Drivers of buyer power in the pharmaceuticals market in Spain, 2017

Figure 7: Drivers of supplier power in the pharmaceuticals market in Spain, 2017

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Spain, 2017

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Spain, 2017

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Spain, 2017

Figure 11: Almirall S.A.: revenues & profitability

Figure 12: Almirall S.A.: assets & liabilities

Figure 13: AstraZeneca PLC: revenues & profitability

Figure 14: AstraZeneca PLC: assets & liabilities

Figure 15: GlaxoSmithKline Plc: revenues & profitability

Figure 16: GlaxoSmithKline Plc: assets & liabilities


List Of Table

List of Tables

Table 1: Spain pharmaceuticals market value: USD billion, 2013-17

Table 2: Spain pharmaceuticals market geography segmentation: USD billion, 2017

Table 3: Spain pharmaceuticals market share: % share, by value, 2017

Table 4: Spain pharmaceuticals market value forecast: USD billion, 2017-22

Table 5: Almirall S.A.: key facts

Table 6: Almirall S.A.: key financials (USD )

Table 7: Almirall S.A.: key financials (EUR)

Table 8: Almirall S.A.: key financial ratios

Table 9: AstraZeneca PLC: key facts

Table 10: AstraZeneca PLC: key financials (USD )

Table 11: AstraZeneca PLC: key financial ratios

Table 12: GlaxoSmithKline Plc: key facts

Table 13: GlaxoSmithKline Plc: key financials (USD )

Table 14: GlaxoSmithKline Plc: key financials (GBP)

Table 15: GlaxoSmithKline Plc: key financial ratios

Table 16: Spain size of population (million), 2013-17

Table 17: Spain gdp (constant 2005 prices, USD billion), 2013-17

Table 18: Spain gdp (current prices, USD billion), 2013-17

Table 19: Spain inflation, 2013-17

Table 20: Spain consumer price index (absolute), 2013-17

Table 21: Spain exchange rate, 2013-17

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com